quick search
Today:
Home AI

More Articles

Creality Debuts Creality Hi and Introduces Trade-in for K2 Plus Combo at CES 2025

Jan 14, 2025

LAS VEGAS,Jan. 13,2025-- Creality,a global leader in 3D printing,showcased its latest innovations at the Consumer Electronics Show (CES) 2025,with a focus on empowering creativity and advancing 3D pr

Telix Presentation to the 43rd Annual J.P. Morgan Healthcare Conference

Jan 14, 2025

MELBOURNE,Australiaand INDIANAPOLIS,Jan. 14,2025-- Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company) today advises that Dr. Christian Behrenbruch,Managing Director and Group CEO,

Petnow Expands Its Presence in Japan with TV Recognition and Interpets 2025 Participation

Jan 14, 2025

TOKYO,Jan. 14,2025-- Petnow Inc.,a pioneering pet tech company,is expanding its footprint in Japan following the app\'s release in October 2024. Strengthening its presence,Petnow recently received nat

MicroAire appoints Remco Maljers as Head of International Sales

Jan 14, 2025

CHARLOTTESVILLE,Va.,Jan. 14,2025-- MicroAire Surgical Instruments,a Marmon Holdings | Berkshire Hathaway company focused on plastic and upper extremity surgery,is pleased to announce the appointment

GlobalTix Named VinWonders' Growth Partner of the Year 2024

Jan 14, 2025

HO CHI MINH CITY,Vietnam,Jan. 14,2025-- GlobalTix,Asia\'s leading ticketing and marketplace distribution platform,has been named "Growth Partner of the Year" by VinWonders,Vietnam\'s premie

Gianna Lullume Baby Soother Device Officially Launches on Kickstarter

Jan 14, 2025

HONG KONG,Jan. 13,2025-- Gianna Lullume,an innovative brand committed to improving infant sleep and promoting family well-being,is proud to announce the official launch of its crowdfunding campaign on

Regor Releases Phase 2a Topline Results for RGT-075, an Oral Once-daily Small Molecule GLP-1R Agonist, and Begins Phase 2b Study in the US for the Treatment of Obesity

Jan 13, 2025

Regor announced its 12-week single-dose Phase 2a trial results for RGT-075,a once-daily oral GLP-1RA,reporting 5% placebo-adjusted weight-loss with no plateau

Skyee Receives In-Principle Approval (IPA) for Major Payment Institution License (MPI) from the Monetary Authority of Singapore (MAS)

Jan 13, 2025

SINGAPORE,Jan. 13,2025-- Skyee Pte. Ltd. ("Skyee") is excited to announce that it has been granted In-Principle Approval (IPA) for the Major Payment Institution (MPI) license from the Moneta

TIER IV secures permit for Level 4 autonomous driving in Nagano Prefecture

Jan 11, 2025

TOKYO,Jan. 10,2025--TIER IV,the pioneering force behind the world\'s first open-source software for autonomous driving,has secured a permit for Level 4 operations in Shiojiri,Nagano Prefecture. This

DIOSynVax Announces a new Advisory Board as it drives the clinical development of its NextGen Influenza Vaccines including Bird-Flu

Jan 10, 2025

CAMBRIDGE,England and SAN DIEGO,Jan. 9,2025-- DIOSynVax,a clinical-stage biotechnology company at the forefront of developing innovative,broadly protective vaccines,built on the safety demonstrated by

1 ... 46 47 48 49 50 51 52 ... 134

Quick Search

Official Affairs is a reliable source for the latest regional news, corporate updates, and official announcements, providing unbiased reporting and in-depth insights into corporate affairs.

© OfficialAffairs